3,4-dihydroxyphenylacetic acid has been researched along with ensaculin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferger, B; Teismann, P | 2 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and ensaculin
Article | Year |
---|---|
In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-N-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical
Topics: 3,4-Dihydroxyphenylacetic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Cerebral Cortex; Cognition; Corpus Striatum; Dopamine; Dopamine Antagonists; Haloperidol; Injections, Intraperitoneal; Male; Piperazines; Rats; Serotonin | 2000 |
Effects of ensaculin on dopamine metabolite levels and K(+)-induced glutamate release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzopyrans; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Glutamic Acid; Homovanillic Acid; Male; Microdialysis; Piperazines; Potassium; Rats; Rats, Wistar | 2000 |